Science ❯ Pharmacology

Psychedelics

Clinical Trials Ibogaine Drug Development MDMA Drug Compounds Substance Use Disorders 5-HT2A Receptor Agonists Clinical Research Therapeutic Uses Drug Efficacy 5-MeO-DMT MDMA History Serotonin Receptors Therapeutic Effects

University of Miami Transfers 1994 Ibogaine IND to Federal Authorities

The gift gives federal agencies access to a decades-old FDA application that could speed regulatory review and shape new clinical work on the drug.

FDA Fast-Tracks Reviews for Psilocybin and Methylone After Trump Order

Definium Therapeutics Jumps to 52-Week High After Trump Order on Psychedelic Treatments

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion